All stocks Β· NOVARTIND
NI

Novartis India Limited.

NOVARTIND BSE Drug Manufacturers - Specialty & Generic Healthcare

Novartis India Limited is involved in the pharmaceutical business in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products und…

ISIN INE234A01025
Listed β€”
Quarters tracked 13
Filings 19 docs

About

Novartis India Limited is involved in the pharmaceutical business in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neuroscience products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is headquartered in Mumbai, India. As of July 29, 2026, Novartis India Limited operates as a subsidiary of Waverise Investments Limited.

Key Metrics

as of Sep 2026
Market Cap4,066 Cr
P/E41.60
Div Yield1.52 %
Book Valueβ‚Ή331.00
52w Highβ‚Ή1,780.00
52w Lowβ‚Ή750.00
Face Valueβ‚Ή5.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 104.00 91.00 86.00 90.00 88.00 84.00 93.00 87.00 92.00 81.00 85.00 79.00 91.00
Expenses 69.00 70.00 64.00 66.00 60.00 60.00 67.00 69.00 68.00 70.00 65.00 62.00 73.00
Operating Profit 35.00 21.00 22.00 24.00 27.00 24.00 26.00 18.00 24.00 11.00 20.00 17.00 17.00
OPM % 34.00 23.00 26.00 26.00 31.00 29.00 28.00 21.00 26.00 14.00 23.00 21.00 19.00
Other Income 9.00 10.00 9.00 9.00 11.00 11.00 11.00 10.00 10.00 10.00 22.00 17.00 12.00
Depreciation 0.00 0.00 0.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 1.00 2.00
Interest 0.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00 0.00
Profit before tax 43.00 30.00 30.00 33.00 37.00 34.00 35.00 28.00 34.00 21.00 41.00 32.00 28.00
Tax % 25.00 16.00 46.00 26.00 26.00 14.00 28.00 26.00 24.00 31.00 36.00 27.00 27.00
Net Profit 32.00 25.00 16.00 24.00 28.00 29.00 25.00 20.00 26.00 15.00 27.00 24.00 20.00
EPS in Rs 13.05 10.23 6.52 9.81 11.19 11.87 10.31 8.27 10.42 5.95 10.76 9.59 8.21

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 354.00356.00335.00379.00400.00381.00438.00491.00564.00656.00690.00870.00
Expenses 260.00265.00270.00314.00373.00355.00426.00478.00570.00631.00656.00874.00
Operating Profit 94.0091.0065.0065.0027.0027.0012.0012.00-6.0025.0034.00-4.00
OPM % 27.0026.0019.0017.007.007.002.802.50-1.103.805.00-0.40
Other Income 39.0042.0062.0058.00-17.0033.0036.0078.00172.0071.00207.00101.00
Interest 1.001.001.002.005.008.006.002.006.001.000.000.00
Depreciation 2.002.003.006.0010.0012.0013.003.003.004.003.004.00
Profit before tax 130.00130.00123.00115.00-4.0040.0029.0086.00158.0092.00237.0093.00
Tax % 28.0023.0031.0010.00-3.0048.0065.0040.0050.0038.0016.0015.00
Net Profit 93.00101.0085.00103.00-4.0021.0010.0052.0078.0057.00198.0079.00
EPS in Rs 37.7440.8734.5041.86-1.518.464.0820.9731.7420.3362.0424.75
Dividend Payout % 66.0061.0072.00113.00-663.00118.00245.0048.0032.0049.0016.0040.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 12.0012.0012.0012.0012.0012.0012.0012.0012.0014.0016.0016.00
Reserves 805.00773.00732.00763.00679.00699.00708.00747.00721.00906.001,178.00986.00
Borrowings 3.005.007.0022.0024.0062.0068.000.000.000.000.000.00
Other Liabilities 157.00158.00173.00186.00242.00229.00289.00223.00377.00230.00239.00244.00
Total Liabilities 978.00948.00925.00983.00958.001,002.001,078.00982.001,111.001,150.001,433.001,246.00
Fixed Assets 3.005.007.0019.0024.0064.0076.0015.005.006.006.008.00
CWIP 0.000.000.000.000.000.000.000.000.000.000.000.00
Investments 0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets 975.00943.00918.00964.00934.00938.001,001.00967.001,106.001,144.001,426.001,238.00
Total Assets 978.00948.00925.00983.00958.001,002.001,078.00982.001,111.001,150.001,433.001,246.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 47.0075.00113.0045.0039.00-69.00-23.00-194.00161.00-41.0057.00-60.00
Cash from Investing Activity 18.00-3.0033.00-153.0087.0095.0056.00274.0069.00424.00-630.00719.00
Cash from Financing Activity -64.00-64.00-121.00-30.00-36.00-37.00-41.00-30.00-268.00-332.00-39.00-38.00
Net Cash Flow 0.007.0026.00-139.0090.00-11.00-9.0050.00-38.0051.00-612.00622.00
Free Cash Flow 46.0075.00113.0045.0038.00-69.00-24.00-208.00160.00-44.0054.00-64.00
CFO/OP % 87.0099.00115.0065.00210.00-127.00124.00-1,210.00-3,503.0013.00398.00601.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 38.0041.0045.0035.0041.0037.0031.0034.0028.0023.0027.0035.00
Inventory Days 98.0074.0082.0099.00117.00119.00117.00111.0084.00104.0092.00103.00
Days Payable 101.0093.00112.00108.00148.00137.00145.00168.00158.0087.0089.0098.00
Cash Conversion Cycle 36.0022.0015.0026.0010.0019.003.00-23.00-45.0040.0030.0040.00
Working Capital Days -46.00-45.00-59.00-37.00-23.0062.00-1.007.00-99.00-14.00-35.006.00
ROCE % 16.0017.0016.0015.006.006.005.0012.0017.009.0022.009.00

Shareholding Pattern

% holding β€” latest first
Holder Jul 2026 Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023
Promoters 70.68 70.68 70.68 70.68 70.68 70.68 70.68 70.68 70.68 70.68 70.68 70.68
FIIs 0.15 0.16 0.17 0.19 0.19 0.19 0.19 0.19 0.19 0.19 0.19 0.19
DIIs 1.39 1.35 0.53 0.63 0.53 0.53 0.53 0.53 0.52 0.52 0.52 0.52
Public 27.79 27.81 28.60 28.50 28.61 28.60 28.61 28.60 28.61 28.60 28.61 28.60
No. of Shareholders 36,706 36,502 38,116 39,468 39,353 39,040 39,133 38,926 39,596 39,265 41,239 43,128

Corporate Actions

26 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Dividend 23 Jul 2025 23 Jul 2025 β€” 25.00
Dividend 23 Jul 2024 β€” β€” 25.00
Dividend 20 Jul 2023 β€” β€” 37.50 NSE/BSE dividend mismatch: BSE/NSE=10.0; BSE/NSE=37.5
Dividend 20 Jul 2023 β€” β€” 10.00 NSE/BSE dividend mismatch: BSE/NSE=10.0; BSE/NSE=37.5
Dividend 20 Jul 2022 β€” β€” 10.00
Dividend 17 Aug 2021 β€” β€” 10.00
Dividend 29 Jul 2020 β€” β€” 10.00
Dividend 31 Jul 2019 β€” β€” 10.00
Dividend 18 Jul 2018 β€” β€” 10.00
Other 07 Dec 2017 08 Dec 2017 β€” β€” Buy Back of Shares
Dividend 19 Jul 2017 β€” β€” 10.00
Dividend 21 Jul 2016 22 Jul 2016 β€” 10.00
Other 21 Jul 2016 22 Jul 2016 β€” β€” Buy Back of Shares
Dividend 14 Jul 2015 β€” β€” 10.00
Dividend 16 Jul 2014 β€” β€” 10.00
Dividend 16 Jul 2013 β€” β€” 10.00
Dividend 18 Jul 2012 β€” β€” 10.00
Dividend 18 Jul 2011 β€” β€” 10.00
Dividend 21 Jul 2010 β€” β€” 10.00
Dividend 08 Jul 2009 β€” β€” 10.00
Dividend 07 Jul 2008 β€” β€” 10.00
Dividend 02 Jul 2002 β€” β€” 7.50
Dividend 08 Oct 2001 β€” β€” 7.50
Dividend 03 Oct 2001 β€” β€” 7.50
Other 06 Nov 2000 20 Nov 2000 β€” β€” Scheme of Arrangement
Other 06 Nov 2000 20 Nov 2000 β€” β€” Reduction of Capital

Announcements

5 filings